SeqLL, Inc. Files Amendment 11 to S-1 Registration Statement

TL;DR

<b>SeqLL, Inc. has filed an eleventh amendment to its S-1 registration statement, indicating ongoing preparations for a public offering.</b>

AI Summary

SeqLL, Inc. (SQLLW) filed a Amended IPO Registration (S-1/A) with the SEC on January 31, 2024. SeqLL, Inc. filed an S-1/A (Amendment No. 11) with the SEC on January 31, 2024. The filing pertains to a registration statement under the Securities Act of 1933. The company's principal executive offices are located at 3 Federal Street, Billerica, MA 01821. Daniel Jones is listed as the Chief Executive Officer. The filing indicates that securities may be offered on a delayed or continuous basis pursuant to Rule 415.

Why It Matters

For investors and stakeholders tracking SeqLL, Inc., this filing contains several important signals. This amendment signifies continued progress in the company's journey towards becoming a publicly traded entity, suggesting potential new investment opportunities. The filing provides updated details and disclosures required for a securities registration, offering insights into the company's structure and offering strategy.

Risk Assessment

Risk Level: low — SeqLL, Inc. shows low risk based on this filing. The filing is an amendment to a registration statement, which is a standard procedural step for companies preparing for an IPO and does not contain new material financial or operational information that would significantly alter the risk profile.

Analyst Insight

Monitor future filings for the effectiveness of the registration statement and details regarding the proposed public offering.

Key Numbers

• 2024-01-31 — Filing Date (Date of filing Amendment No. 11)
• 11 — Amendment Number (Amendment number to the registration statement)
• 333-272908 — SEC File Number (Registration number)
• 1933 — Securities Act Year (Securities Act of 1933)

Key Players & Entities

• SeqLL, Inc. (company) — Filer name
• Daniel Jones (person) — Chief Executive Officer
• Pryor Cashman LLP (company) — Legal counsel
• Davidoff Hutcher & Citron LLP (company) — Legal counsel
• Loeb & Loeb LLP (company) — Legal counsel
• 317 New Boston Street (location) — Business address
• 3 Federal Street (location) — Principal executive offices
• 333-272908 (registration_number) — SEC file number

Forward-Looking Statements

• SeqLL, Inc. will initiate a public offering of securities within the next 6 months. (SeqLL, Inc.) — medium confidence, target: 2024-07-31

FAQ

Industry Context

SeqLL, Inc. operates within the services sector, specifically in help supply services, as indicated by its SIC code.

Regulatory Implications

The filing is made under the Securities Act of 1933, which governs the registration of securities offerings in the United States.

What Investors Should Do

1. Review the full S-1/A filing for any new disclosures or changes to the offering terms.
2. Track the SEC's review process and any subsequent amendments or effectiveness declarations.
3. Monitor market conditions and investor sentiment leading up to the potential IPO.

Key Dates

• 2024-01-31: Filing of Amendment No. 11 to S-1 Registration Statement — Indicates continued progress in the company's IPO process.

Year-Over-Year Comparison

This is an amendment to a previous filing, indicating ongoing procedural steps rather than a new initial filing.

Key Financial Figures

• $20,000,000 — Y PROSPECTUS (Currently SeqLL Inc.) $20,000,000 2,000,000 Units Each Unit consisting
• $0.00001 — a0;one share of common stock, par value $0.00001 per share; and (ii) one Series A Warran
• $13.00 — is exercisable at an exercise price of $13.00 per share (130% of the offering price p
• $20.00 — is exercisable at an exercise price of $20.00 per share (200% of the offering price p
• $10.00 — at an assumed public offering price of $10.00 per Unit. We are also offering to thos
• $0 — d to the public in this offering, minus $0.0001, and the exercise price of each Pr
• $0.0001 — of each Pre -Funded Warrant will equal $0.0001 per share of common stock. For each Pre
• $4.46 — last bid price of our common stock was $4.46. The public offering price of the Units
• $3,000,000 — ll receive additional gross proceeds of $3,000,000, less a 7% commission fee to the underw

Filing Documents

• fs12024a11_seqllinc.htm (S-1/A) — 9795KB
• fs12024a11ex4-6_seqllinc.htm (EX-4.6) — 114KB
• fs12024a11ex4-7_seqllinc.htm (EX-4.7) — 95KB
• fs12024a11ex4-8_seqllinc.htm (EX-4.8) — 94KB
• fs12024a11ex10-17_seqllinc.htm (EX-10.17) — 73KB
• fs12024a11ex23-1_seqllinc.htm (EX-23.1) — 2KB
• fs12024a11ex23-2_seqllinc.htm (EX-23.2) — 2KB
• ex23-1_001.jpg (GRAPHIC) — 2KB
• tatlantic_logo.jpg (GRAPHIC) — 64KB
• tefhutton_logo.jpg (GRAPHIC) — 20KB
• timage_001.jpg (GRAPHIC) — 298KB
• 0001213900-24-008100.txt (&nbsp;) — 10705KB

Risk Factors

Risk Factors &#x00a0; 14 Cautionary Note&#x00a0;Regarding Forward-Looking Statements &#x00a0; 36

Use of Proceeds

Use of Proceeds &#x00a0; 38 Dividend Policy &#x00a0; 39 Capitalization &#x00a0; 40 Market for Common Stock and Related Stockholder Matters &#x00a0; 42

Dilution

Dilution &#x00a0; 43 Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations of Lyneer &#x00a0; 45 Our Selected Historical Consolidated Financial Data &#x00a0; 64 Unaudited Pro Forma Condensed Combined Financial Information &#x00a0; 65 Equivalent and Comparative Per Share Information &#x00a0; 76

Business

Business &#x00a0; 77 Information About Atlantic &#x00a0; 84 Management &#x00a0; 86 Compensation of Executive Officers and Directors &#x00a0; 92 Certain Relationships and Related Person Transactions &#x00a0; 102 Principal Stockholders &#x00a0; 104

Description of Capital Stock

Description of Capital Stock &#x00a0; 106 Shares Eligible for Future Sale &#x00a0; 114

Underwriting

Underwriting &#x00a0; 116 Legal Matters &#x00a0; 121 Experts &#x00a0; 121 Incorporation of Certain Information by Reference &#x00a0; 122 Where You Can Find Additional Information &#x00a0; 123 Index to Financial Statements &#x00a0; F-1 We have not, and the underwriters have not, authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectus prepared by or on behalf of us or to which we have referred you. We and the underwriters take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the securities offered hereby, but only under the circumstances and in the jurisdictions where it is lawful to do so. The information contained in this prospectus or in any applicable free writing prospectus is current only as of its date, regardless of its time of delivery or any sale of our securities. Our business, financial condition, results of operations and prospects may have changed since that date. We have not, and the underwriters have not, authorized anyone to provide you with information that is different from that contained in this prospectus or in any free writing prospectus we may authorize to be delivered or made available to you. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. Neither the delivery of this prospectus nor the sale of our securities means that the information contained in this prospectus or any free writing prospectus is correct after the date of this prospectus or such free writing prospectus. This prospectus is not an offer to sell or the solicitation of an offer to buy our securities in any circumstances under which the offer or solicitation is unlawful. For investors outside the United&#x00a0;States: We have not, and the underwriters

View Full Filing

View this S-1/A filing on SEC EDGAR